Related Experiment Video
Updated: Dec 2, 2025

Cell-based Assay to Study Antibody-mediated Tau Clearance by Microglia
Published on: November 9, 2018
Novel target for treating Alzheimer's Diseases: Crosstalk between the Nrf2 pathway and autophagy
Weiwei Zhang1, Cong Feng1, Hong Jiang1
1Department of Health Laboratory Technology, School of Public Health, China Medical University, No. 77 Puhe Road, Shenyang North New Area, Shenyang, Liaoning 110122, People's Republic of China.
Abstract:
In mammals, the Keap1-Nrf2-ARE pathway (henceforth, "the Nrf2 pathway") and autophagy are major intracellular defence systems that combat oxidative damage and maintain homeostasis. p62/SQSTM1, a ubiquitin-binding autophagy receptor protein, links the Nrf2 pathway and autophagy. Phosphorylation of p62 dramatically enhances its affinity for Keap1, which induces Keap1 to release Nrf2, and the p62-Keap1 heterodimer recruits LC3 and mediates the permanent degradation of Keap1 in the selective autophagy pathway. Eventually, Nrf2 accumulates in the cytoplasm and then translocates into the nucleus to activate the transcription of downstream genes that encode antioxidant enzymes, which protect cells from oxidative damage. Since Nrf2 also upregulates the expression of the p62 gene, a p62-Keap1-Nrf2 positive feedback loop is created that further enhances the protective effect on cells. Studies have shown that the p62-activated noncanonical Nrf2 pathway is an important marker of neurodegenerative diseases. The p62-Keap1-Nrf2 positive feedback loop and the Nrf2 pathway are involved in eliminating the ROS and protein aggregates induced by AD. Therefore, maintaining the homeostasis of the p62-Keap1-Nrf2 positive feedback loop, which is a bridge between the Nrf2 pathway and autophagy, may be a potential target for the treatment of AD.
Insights
The Keap1-Nrf2-ARE pathway and autophagy, linked by p62, protect cells from oxidative damage. Maintaining this p62-Keap1-Nrf2 feedback loop may treat neurodegenerative diseases like Alzheimer's.
Area of Science:
- Cellular Biology
- Molecular Biology
- Neuroscience
Background:
- The Keap1-Nrf2-ARE pathway and autophagy are critical cellular defense systems against oxidative stress and for maintaining homeostasis.
- p62/SQSTM1 acts as a crucial link between the Nrf2 pathway and autophagy, mediating the interaction between Keap1 and Nrf2.
- Dysregulation of this pathway is implicated in neurodegenerative diseases, including Alzheimer's disease (AD).
Purpose of the Study:
- To elucidate the role of the p62-Keap1-Nrf2 positive feedback loop in cellular defense mechanisms.
- To investigate the involvement of the Nrf2 pathway and autophagy in the context of neurodegenerative diseases.
- To explore the therapeutic potential of targeting the p62-Keap1-Nrf2 pathway for AD treatment.
Main Methods:
- Investigated the molecular interactions between p62, Keap1, and Nrf2.
- Examined the role of p62 phosphorylation in regulating Keap1-Nrf2 binding and subsequent Nrf2 activation.
- Studied the involvement of selective autophagy (LC3 recruitment) in Keap1 degradation.
- Analyzed the positive feedback loop created by Nrf2-mediated upregulation of p62.
- Correlated p62-activated Nrf2 pathway activity with markers of neurodegeneration.
Main Results:
- Phosphorylation of p62 enhances its affinity for Keap1, leading to Nrf2 release and subsequent nuclear translocation.
- The p62-Keap1 heterodimer recruits LC3, facilitating Keap1 degradation via selective autophagy.
- A positive feedback loop is established where Nrf2 upregulates p62 expression, amplifying cellular protection.
- The p62-activated Nrf2 pathway is identified as a significant marker in neurodegenerative diseases.
- This pathway is involved in clearing reactive oxygen species (ROS) and protein aggregates in AD.
Conclusions:
- The p62-Keap1-Nrf2 positive feedback loop is a vital bridge between the Nrf2 pathway and autophagy, crucial for cellular defense.
- This pathway plays a significant role in mitigating oxidative damage and protein aggregation characteristic of AD.
- Maintaining the homeostasis of the p62-Keap1-Nrf2 pathway presents a promising therapeutic target for Alzheimer's disease and other neurodegenerative conditions.
Related Concept Videos
Alzheimer's Disease: Treatment
Autophagy
An autophagic pathway consists of a series of signaling events activated in response to diverse stress and physiological conditions such as food deprivation,...
Alzheimer's Disease: Overview
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
Electron Transport Chain: Complex I and II
ROS generation is regulated and maintained at moderate levels necessary...
NF-κB-dependent Signaling Pathway
NF-κB-dependent Signaling Mechanism
The...
Enzyme-linked Receptors
Neurotrophin (NT) receptors are a family of RTKs, including trkA, trkB, and trkC (tropomyosin-related kinase) receptors. TrkA is specific for nerve growth factor (NGF), neurotrophin-6, and neurotrophin-7. TrkB binds...
